pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05669989: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

    Sponsor: Sanofi. Phase: PHASE2. Conditions: Plasma Cell Myeloma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06139874: Thrive Intervention in Schools

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Childhood Mental Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00540774: Optical Sensor for Photodynamic Detection of Oral Pathology

    Sponsor: University of California, Irvine. Phase: NA. Conditions: Mouth Diseases

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05515874: Predicting Stroke Risk in ICAD With Novel MRI

    Sponsor: Northwestern University. Phase: PHASE4. Conditions: Intracranial Atherosclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07572474: Correlation Between Pinch Grip and Handwriting in School-Age Children

    Sponsor: October 6 University. Phase: . Conditions: Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06831318: Community Health Worker-Led Transition Support for Persons Living With Dementia and Caregivers

    Sponsor: University of Texas at Austin. Phase: NA. Conditions: Cognitive Impairment, Dementia, Memory Deficits

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06813118: Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS Case

    Sponsor: HITEC-Institute of Medical Sciences. Phase: PHASE1. Conditions: Polycystic Ovarian Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06832618: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

    Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07522918: Single-Session Extraoral PBM After Third Molar Extraction

    Sponsor: Konya Necmettin Erbakan Üniversitesi. Phase: NA. Conditions: Impacted Mandibular Third Molar, Edema, Trismus, Postoperative Pain

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07465497: Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

    Sponsor: Instituto Jalisciense de Cancerologia. Phase: NA. Conditions: Chemobrain, Breast Cancer, Inflammatory Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05756413: Birth to Three - Cavity Free

    Sponsor: University of Iowa. Phase: NA. Conditions: Caries,Dental

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06498713: Patient Controlled Administration of Liquid Acetaminophen

    Sponsor: Yale University. Phase: PHASE1. Conditions: Pain, Pain, Postoperative

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06201429: A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.

    Sponsor: Renovo Concepts, Inc.. Phase: NA. Conditions: Clinical Need for Craniotomy or Craniectomy, Clinical Need for Cranioplasty

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06353529: Postop Pain Management in Pituitary Tumour Patients

    Sponsor: Hamilton Health Sciences Corporation. Phase: PHASE4. Conditions: Pituitary, Pain, Postoperative

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07359729: Deep Breathing and Virtual Reality for Venipuncture Pain

    Sponsor: Universidad Autónoma del Estado de Hidalgo. Phase: NA. Conditions: Pain Management, Anxiety, Virtual Reality, Breathing Exercises, Pain Measurement, Patient Satisfaction

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07422051: Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

    Sponsor: Spanish National Research Council. Phase: PHASE2. Conditions: Atherosclerosis Cardiovascular Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07450651: Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis

    Sponsor: Beijing Friendship Hospital. Phase: . Conditions: Hepatitis B Virus Related Cirrhosis, Portal Hypertension Related to Cirrhosis, Esophagogastric Varices

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04750551: BreEStim for Post-Stroke Motor Recovery

    Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Motor Recovery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00549731: Participant Database for Autism Research Studies

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Autism Spectrum Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05768802: Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation

    Sponsor: Boninger, Michael, MD. Phase: NA. Conditions: Amputation, Amputation; Traumatic, Hand

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05931302: Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT

    Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: NA. Conditions: Lobular Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06065202: Personalized Nutrition to Improve Recovery in Trauma

    Sponsor: Duke University. Phase: PHASE2. Conditions: Abdominal Trauma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06386653: Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

    Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences. Phase: PHASE1. Conditions: Lung Cancer, Ovarian Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379437: Haematococcus Pluvialis Astaxanthin for Brain Aging

    Sponsor: Capital Medical University. Phase: NA. Conditions: Brain Aging

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05469737: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

    Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Myelodysplastic Syndromes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05359653: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

    Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Benign

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03986437: A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.

    Sponsor: Institut Claudius Regaud. Phase: . Conditions: Differentiated Thyroid Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04658251: Study of New Mutations in Cone Disorders

    Sponsor: University Hospital, Lille. Phase: . Conditions: Retinal Dystrophy, Cone-Rod, Cone Dystrophy, Cone Rod Dystrophy, Macular Degeneration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06887829: Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Osteoarthritis, Knee

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05078229: Evaluating Stress Management Among Allogeneic HCT Caregivers

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Burden, Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07023029: A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

    Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Healthy Volunteers, Sickle Cell Disease, Thalassemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06771531: Brain Stimulation for Foot-sole Sensation in Older Adults With Foot-sole Somatosensory Deficits

    Sponsor: Hebrew SeniorLife. Phase: NA. Conditions: Somatosensory Function, Balance Control, Mobility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07613931: Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment

    Sponsor: Tactile Medical. Phase: EARLY_PHASE1. Conditions: Lower Extremity Lymphedema

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07667231: PENG+LFCN Block vs QIPB for Total Hip Arthroplasty

    Sponsor: Antalya City Hospital. Phase: NA. Conditions: Quadro-Iliac Plane Block, Pericapsular Nerve Group Block (PENG Block), Hip Arthroplasty, Total, Pain Management, Lateral Femoral Cutaneous Nerve Block

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07490002: Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

    Sponsor: Changhai Hospital. Phase: PHASE2. Conditions: Esophageal Squamous Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05459753: Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)

    Sponsor: University of Michigan. Phase: NA. Conditions: Parkinson Disease, Progressive Supranuclear Palsy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07567053: Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study

    Sponsor: Cook Children's Health Care System. Phase: NA. Conditions: Cerebral Palsy, Typically Developing Children

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05306353: CD40L Antagonism in Rheumatoid Arthritis (RA)

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07396337: Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.

    Sponsor: Changzhou Qianhong Bio-pharma Co., Ltd.. Phase: PHASE2. Conditions: Acute Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07489651: RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

    Sponsor: Reunion Neuroscience Inc. Phase: PHASE2. Conditions: Generalized Anxiety Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06084429: Developing School Health Champions to Increase Health Literacy Both in School Adolescents and Community People Through Providing Health Education by the School Nurses in Bangladesh: Community-based Pre- and Post-experimental Design

    Sponsor: Hiroshima University. Phase: NA. Conditions: Health Literacy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07312929: Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis

    Sponsor: University of Alberta. Phase: . Conditions: Renal Dialysis, Renal Replacement Therapy, Renal Diseases, Quality Health Care

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05746429: Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer

    Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Bone Sarcoma, Childhood Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05452031: A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Sleep

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05367102: Supporting Healthy Relationships Program for FRAMEWorks (SHR FRAMEWorks)

    Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Parenting, Family Relations, Relationship, Family

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07326202: Gait Asymmetry And Its Relationship With Neck Pain And Muscles Strength In Patients With Cervical Radiculopathy

    Sponsor: Cairo University. Phase: . Conditions: Cervical Radiculopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06857851: Optimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease

    Sponsor: VA Office of Research and Development. Phase: . Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02811029: Language and Motricity in Preterm School Age Children

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Infant, Premature

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06664229: Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

    Sponsor: Sunmi Song. Phase: NA. Conditions: Dementia, Mild, Accidental Falls, Mild Cognitive Impairment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07364851: A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

    Sponsor: Daewon Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Volunteer

    full page →ctgov ↗
    ← prev
    page 83 of 98
    next →